Fondaparinux: another potential treatment for heparin-induced thrombocytopenia type II?

被引：0
作者：
Honore, Patrick M. [1 ]
Jacobs, Rita [1 ]
Hendrickx, Inne [1 ]
De Waele, Elisabeth [1 ]
Van Gorp, Viola [1 ]
Spapen, Herbert D. [1 ]
机构：
[1] Vrije Univ Brussel, Univ Ziekenhuis Brussel, ICU Dept, 101 Laarbeeklaan, B-1090 Brussels, Belgium
来源：
CRITICAL CARE | 2016年 / 20卷
关键词：
Renal Replacement Therapy; Acute Kidney Injury; Continuous Renal Replacement Therapy; Fondaparinux; Argatroban;
D O I：
10.1186/s13054-016-1196-6
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Heparin-Induced Thrombocytopenia Type II Because of Heparin-Coated Polytetrafluoroethylene Graft Used to Bypass
    Gabrielli, Roberto
    Siani, Andrea
    Rosati, Maria Sofia
    Antonelli, Roberto
    Accrocca, Federico
    Giordano, Gioacchino Alessandro
    Marcucci, Giustino
    ANNALS OF VASCULAR SURGERY, 2011, 25 (06) : 840.e9 - 840.e12
  • [42] Management of heparin-induced thrombocytopenia
    Jaax, Miriam E.
    Greinacher, Andreas
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (07) : 987 - 1006
  • [43] Heparin-induced thrombocytopenia: Update
    Camoin-Jau, L.
    Mariotti, A.
    Suchon, P.
    Morange, P. -E.
    REVUE DE MEDECINE INTERNE, 2022, 43 (01): : 18 - 25
  • [44] Pharmacotherapy of heparin-induced thrombocytopenia
    Dager, WE
    White, RH
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (06) : 919 - 940
  • [45] What’s new about heparin-induced thrombocytopenia type II
    Yasser Sakr
    Intensive Care Medicine, 2015, 41 : 1824 - 1827
  • [46] Heparin-induced thrombocytopenia: Treatment options and special considerations
    Dager, William E.
    Dougherty, John A.
    Nguyen, Phuong H.
    Militello, Michael A.
    Smythe, Maureen A.
    PHARMACOTHERAPY, 2007, 27 (04): : 564 - 587
  • [47] Systematic review of fondaparinux for heparin-induced thrombocytopenia: When there are no randomized controlled trials
    Linkins, Lori-Ann
    Hu, George
    Warkentin, Theodore E.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2018, 2 (04) : 678 - 683
  • [48] Use of fondaparinux (ARIXTRA®) in a dialysis patient with symptomatic heparin-induced thrombocytopaenia type II
    Haase, M
    Bellomo, I
    Rocktaeschel, J
    Ziemer, S
    Kiesewetter, H
    Morgera, S
    Neumayer, HH
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (02) : 444 - 446
  • [49] Heparin-induced thrombocytopenia:: Pathophysiology and new treatment options
    Harenberg, J
    Jörg, I
    Fenyvesi, T
    PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2002, 32 (5-6) : 289 - 294
  • [50] Dalteparin sodiumDelayed-onset heparin-induced thrombocytopenia during fondaparinux prophylaxis: case report
    Reactions Weekly, 2009, 1234 (1) : 15 - 15
12345